| 形态 | Liquid |
|---|---|
| 宿主种属 | Human |
| 抗体亚型 | Fusion - (GCG (glucagon) 98-127 (glucagon-like pep |
| 纯度 | >95% purity as determined by SDS-PAGE. |
| 纯化方式 | Purified by ion exchange chromatography. |
| 浓度 | 0.5mg/ml |
| 内毒素水平 | Please contact the lab for this information. |
| 应用 | ELISA, Functional assay, Research in vivo |
| 种属反应性 | Human |
| 靶标 | GLP-1 receptor, Glucagon-like peptide 1 receptor, GLP1R, GLP-1-R, GLP-1R |
| 储存缓冲液 | 0.01M PBS, pH 7.4. |
| 稳定性和储存 | Use a manual defrost freezer and avoid repeated freeze-thaw cycles. Store at 4°C for short-term storage (1-2 weeks). Store at -20°C for up to 12 months. For long-term storage, store at -80°C. |
| 表达系统 | Mammalian Cells |
| 登录号 | P43220 |
| 背景信息 | Liraglutide, 97% similar to native human GLP-1, differs primarily by substituting arginine for lysine at position 34 and involves attaching a C-16 fatty acid (palmitic acid) with a glutamic acid spacer at the remaining lysine residue at position 26. • The physiology of glucagon-like peptide 1., PMID:17928588 • Glucagon-like peptide-1 receptor: mechanisms and advances in therapy., PMID:39289339 • The structure and function of the glucagon-like peptide-1 receptor and its ligands., PMID:21950636 • Structural basis for GLP-1 receptor activation by LY3502970, an orally active nonpeptide agonist., PMID:33177239 • Glucagon-like peptide-1 receptor., PMID:39626623 • Prognostic impact of glucagon-like peptide-1 receptor (GLP1R) expression on cancer survival and its implications for GLP-1R agonist therapy: an integrative analysis across multiple tumor types., PMID:39777709 • Safety issues with glucagon-like peptide-1 receptor agonists (pancreatitis, pancreatic cancer and cholelithiasis): Data from randomized controlled trials., PMID:28244632 • Glucagon-like-peptide 1 receptor agonism and attempted suicide: A Mendelian randomisation study to assess a potential causal association., PMID:38778795 • Glucagon-Like Peptide-1 Receptor Agonism and Suicide Risk: Evidence From Mendelian Randomization., PMID:38879463 • GLP-1, GIP/GLP-1, and GCGR/GLP-1 receptor agonists: Novel therapeutic agents for metabolic dysfunction-associated steatohepatitis., PMID:39735270 |
| 别名 | GSK716155, SyncriaEPERZAN®(EU), TANZEUM®(US) |
| 备注 | For research use only. Not suitable for clinical or therapeutic use. |
| 产品名称 | 点击数 |
|---|---|
| 空肠弯曲菌单克隆抗体 | 7366 |
| 人触珠蛋白单克隆抗体 | 7580 |
| 贾第鞭毛虫单克隆抗体 | 7252 |
| 阿米巴单克隆抗体 | 7736 |
| 胃蛋白酶单克隆抗体 | 7271 |
| 胃蛋白酶原II单克隆抗体 | 7396 |
| 胃蛋白酶原I单克隆抗体 | 7190 |
| 艰难梭菌毒素A单克隆抗体 | 7305 |
| 艰难梭菌毒素B单克隆抗体 | 7601 |
| 艰难梭菌GDH单克隆抗体 | 7557 |
| 诺如病毒单克隆抗体 | 7110 |
| 伤寒沙门氏菌单克隆抗体 | 7229 |
| 鼠疫耶尔森菌F1单克隆抗体 | 6737 |
| 幽门螺杆菌单克隆抗体 | 7237 |
| 钙卫蛋白单克隆抗体 | 7071 |
| 乳铁蛋白单克隆抗体 | 7364 |
| 转铁蛋白单克隆抗体 | 7355 |
| 血红蛋白单克隆抗体 | 7122 |
| 腺病毒单克隆抗体 | 7311 |
| 轮状病毒单克隆抗体 | 7642 |